| A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-796 | Phase III | rekrutiert |
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Trea | Phase III | rekrutiert |
| A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradi | Phase III | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Pl | Phase III | rekrutiert |
| A Platform Study in Non-Small Cell Lung Cancer (NSCLC) | Phase I / Phase II | rekrutiert |
| A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severe | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab a | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs | Phase III | rekrutiert |
| A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in P | Phase III | rekrutiert |
| A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Diseas | Phase II | rekrutiert |
| A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin | — | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembroliz | Phase III | rekrutiert |
| A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neop | Phase I | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Meta | Phase III | rekrutiert |
| A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions | Phase II / Phase III | rekrutiert |
| A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Grow | Phase II | rekrutiert |
| A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia | — | rekrutiert |
| A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult an | Phase III | rekrutiert |
| A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan ( | Phase III | rekrutiert |
| A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemothe | Phase II / Phase III | rekrutiert |
| A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hosp | Phase III | rekrutiert |
| A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chro | Phase II | rekrutiert |
| A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in P | Phase III | rekrutiert |
| A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab Wit | Phase III | rekrutiert |
| A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participan | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to | Phase II | rekrutiert |
| A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial | Phase II | rekrutiert |
| A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants | Phase I / Phase II | rekrutiert |
| A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseas | Phase III | rekrutiert |
| A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People W | Phase III | rekrutiert |
| A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Fa | Phase III | rekrutiert |
| A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD | Phase II | rekrutiert |
| A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma | Phase II / Phase III | rekrutiert |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With | Phase III | rekrutiert |
| Accelerated Treatment of Depressive Patients With tDCS | ohne Phasenangabe | rekrutiert |
| Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in | Phase III | rekrutiert |
| Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting | ohne Phasenangabe | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| CAR-T Long Term Follow Up (LTFU) Study | Phase III | rekrutiert |
| CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer | — | rekrutiert |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer | — | rekrutiert |
| Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello- | Phase III | rekrutiert |
| Cohort Study on Plant-based Diets (COPLANT Study) | — | rekrutiert |
| Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute My | Phase I / Phase II | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Pl | Phase II | rekrutiert |
| De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcino | ohne Phasenangabe | rekrutiert |
| Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Reg | — | rekrutiert |
| Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Brea | Phase II | rekrutiert |
| Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis | Phase I | rekrutiert |
| Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligom | Phase II | rekrutiert |
| Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody | Phase III | rekrutiert |
| Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients | Phase II | rekrutiert |
| Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring S | Phase III | rekrutiert |
| Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopul | Phase II / Phase III | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| European Disease Registry on Retinopathy of Prematurity (ROP) | — | rekrutiert |
| European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] | Phase II | rekrutiert |
| Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FL | Phase II | rekrutiert |
| Fosfomycin I.v. for Treatment of Severely Infected Patients | — | rekrutiert |
| GISAR German Interdisciplinary Sarcoma Registry | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) | Phase III | rekrutiert |
| High-dose Accelerated Theta Burst Stimulation for the Treatment of Alcohol Addiction | ohne Phasenangabe | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lu | ohne Phasenangabe | rekrutiert |
| Intermittent Theta Burst Stimulation for Maintenance Therapy in Depression | ohne Phasenangabe | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH | Phase III | rekrutiert |
| LANDMARK Trial: a Randomised Controlled Trial of Myval THV | ohne Phasenangabe | rekrutiert |
| LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Acti | Phase II | rekrutiert |
| Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdi | — | rekrutiert |
| Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Pha | Phase III | rekrutiert |
| Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL Sy | — | rekrutiert |
| Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses | — | rekrutiert |
| Lung cAncer Robotic Comparative Study | — | rekrutiert |
| Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and | Phase III | rekrutiert |
| Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory M | Phase III | rekrutiert |
| Multicenter Study for Diagnostic Validation of a Laboratory Test for the Diagnosis of Endometrio | — | rekrutiert |
| Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections | Phase III | rekrutiert |
| Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab | Phase II | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) | Phase III | rekrutiert |
| OSsIRIS Study - A Post-market Clinical Follow-up Investigation. | — | rekrutiert |
| Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours U | — | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothel | Phase II / Phase III | rekrutiert |
| Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid T | Phase I / Phase II | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as | Phase III | rekrutiert |
| Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | Phase III | rekrutiert |
| Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorde | — | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Praegnant Breast Cancer: Early/Advanced/Metastatic | — | rekrutiert |
| Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Ad | ohne Phasenangabe | rekrutiert |
| Prospective, Non-Randomised Clinical Trial to Investigate the BeGraft Aortic Stent Graft System | — | rekrutiert |
| Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectio | Phase II | rekrutiert |
| Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma | Phase II | rekrutiert |
| Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer | Phase III | rekrutiert |
| RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | ohne Phasenangabe | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD- | Phase III | rekrutiert |
| Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Cou | Phase IV | rekrutiert |
| Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy | Phase II | rekrutiert |
| Register Schweres Asthma - German Asthma Net e.V. | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advan | — | rekrutiert |
| Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With T | — | rekrutiert |
| Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearran | Phase III | rekrutiert |
| Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Adv | Phase II | rekrutiert |
| Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Folli | Phase III | rekrutiert |
| Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or | Phase II | rekrutiert |
| Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Croh | Phase II | rekrutiert |
| Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants W | Phase II | rekrutiert |
| Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Rea | — | rekrutiert |
| Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Im | Phase III | rekrutiert |
| Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308 | Phase I | rekrutiert |
| TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study | — | rekrutiert |
| Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-r | Phase IV | rekrutiert |
| Tendyne European Experience Registry | — | rekrutiert |
| The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable E | ohne Phasenangabe | rekrutiert |
| The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associate | ohne Phasenangabe | rekrutiert |
| The PERSEVERE Study | ohne Phasenangabe | rekrutiert |
| This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-0682 | Phase III | rekrutiert |
| Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in A | — | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Ultra-high-caloric, Fatty Diet in ALS | ohne Phasenangabe | rekrutiert |
| Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed | Phase II | rekrutiert |
| Vorasidenib Maintenance for IDH Mutant Astrocytoma | Phase III | rekrutiert |
| Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metast | Phase II | rekrutiert |
| Zimmer® Natural Nail® (ZNN) Bactiguard Tibia Post-Market Clinical Follow-up Study | — | rekrutiert |